Safety and Efficacy of Allogeneic NK Cells Therapy in Patients With Advanced Hepatocellular Carcinoma

NCT04162158 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Beijing 302 Hospital

Collaborators